Boricua Youth Study COVID-19 Coping Intervention Study

The current pilot study is a randomized controlled trial with an intervention (n=25 parent-child pairs) and a waitlist control (n=15 parent-child pairs) group that examines the feasibility, acceptability, and preliminary outcomes of the mHealth mindfulness program for parents. Parent participants will utilize a commercially available mobile phone application, Headspace TM, to complete 10-20 minutes of mindfulness exercises daily for six weeks. The investigators will measure the feasibility and acceptability of the mHealth mindfulness program for parents and clinical outcomes in both parents and children and also explore the effects of the intervention on stress markers including cortisol and inflammation (C-reactive protein (CRP) and Interleukin-6 (Il-6)).

Participants will recruit from an existing longitudinal cohort, the Boricua Youth Study (BYS; NYSPI IRB protocols #4187R and #6476) and BYS-ECHO (NYSPI IRB Protocols # 7377). The BYS is an epidemiological study on the development of psychiatric disorders in Puerto Rican children. Participants for the current study are a subsample G1 BYS participants who are parents of youth (G2) ages 3 to 12 years old.

Aim 1: To exam the feasibility and acceptability of an mHealth mindfulness program to reduce psychosocial distress among parents of children between 5 and 12 years old (N=40 parent-child pairs) Aim 2: To test preliminary clinical outcome for parents (psychosocial distress and functioning) and child (behavioral and emotional problems) Exploratory Aim: To explore the effects of an mHealth mindfulness-based intervention (MBI) on stress markers including cortisol and inflammation (CRP and IL-6)

Study procedure:

Intervention group:

• Screen
• Consent
• Randomization
• Baseline assessments for the parent (30 minutes including parent self-reports and parent reports of child) and child self-reports (15 minutes)
• 6-week Intervention with daily assignments (10-20 minutes per day)
• Posttreatment assessments for the parent (40 minutes including self-reports, parent report of child, and a brief exit interview) and child self-reports (15 minutes)
• 4-8 week posttreatment follow up assessments for the parent (5-10 minutes)

Waitlist group :

• Screen
• Consent
• Randomization
• Baseline assessments for the parent (30 minutes including parent self-reports and parent report of child) and child self-report (15 minutes)
• 6-week waitlist
• Post waitlist/Pretreatment for the parent (30 minutes including parent self-reports and parent report of child) and child self-report (15 minutes)
• 6-week Intervention with daily assignments (10-20 minutes per day)
• Posttreatment assessments for the parent (20-30 minutes including parent self-reports, parent report of child, and exit interview)
• 4-8 week posttreatment follow up assessments of parent self-reports (5-10 minutes)

Inclusion criteria

for the BYS parents-

• BYS participants in the NY cohort (BYS-ECHO study record)
• Have a child/children ages 3 to 12 years (BYS-ECHO study record)
• Access to a smartphone, tablet, or computer with at least periodic internet access (Self-report)

Inclusion criteria

for community parents:

• Latinx parents with a child/children ages 3 to 12 years who express interest in the study, self-referred or referred by our community collaborators (Self-report)
• access to a smartphone, tablet, or computer with at least periodic internet access (Self-report)
• Residents of the NYC Metropolitan Area (i.e., individuals living approximately within 1 hour driving distance from NYC) (Self-report. If deemed necessary, research team may ask to check ID or relevant documents to verify information, e.g. name, address, etc)

Exclusion criteria

for all parents:

• Psychiatric risks (e.g., homicidality, suicidality including ideation and attempts, psychosis; answering "yes" to the PHQ-9 suicidal idea question, Q9) (As determined by BYS-ECHO study record or self-report of PHQ-9)
• Severe depressive symptoms (i.e., PHQ-9=20 or above) (Self-report of PHQ-9)

Inclusion criteria

for all children:

• Parents agreed to participate in the current study (Study consent form)
• Ages 3 to 12 (BYS-ECHO study record or parent report of child age)

Exclusion criterion for all children:

• Psychiatric risks (e.g., homicidally, suicidality including ideation and attempts, psychosis) (Parent report on Child Screener)